Research Topic: Medicinal

Global, Regional, and National Burden of Pulmonary Fungal Infections 1990–2021

This study analyzed the global impact of fungal lung infections from 1990 to 2021, finding that about 5.6 million people were affected in 2021 with significant mortality rates. The burden of these infections is particularly high in low- and middle-income countries and affects older individuals more severely. The researchers project that deaths from fungal lung infections will double by 2044, emphasizing the need for better prevention strategies, vaccines, and international cooperation to address this growing health challenge.

Read More »

Deciphering the role of CAPZA2 in neurodevelopmental disorders: insights from mouse models

Scientists studied a gene called CAPZA2 that helps control how brain cells connect to each other. When this gene doesn’t work properly, mice had trouble learning, remembering things, and interacting socially, similar to intellectual disability in humans. The researchers found that the problem happens because the connections between brain cells become abnormal and don’t mature properly. This research helps explain why some people with mutations in this gene have developmental difficulties and could lead to new treatments.

Read More »

Two Cases of Curvularia geniculata Keratitis Successfully Treated with Natamycin-Based Therapy

Two patients developed rare fungal eye infections caused by Curvularia geniculata after eye injuries from plant material. The infections caused corneal ulcers with characteristic feathery infiltrates. Both patients were successfully treated using natamycin eyedrops, either alone or combined with voriconazole, and both recovered excellent vision. Accurate identification of the fungus using genetic testing confirmed the diagnosis and helped guide treatment decisions.

Read More »

Prevalence of Compartment Syndrome and Disseminated Intravascular Coagulation following Rhabdomyolysis; a Systematic Review and Meta-Analysis

This study analyzed twenty research papers to understand how often two serious complications occur in patients with rhabdomyolysis, a condition involving muscle damage. Compartment syndrome, where pressure builds up around muscles limiting blood flow, occurred in about 4% of cases overall but was slightly more common in severe cases. Disseminated intravascular coagulation, a dangerous blood clotting disorder, occurred in about 8% of patients. These findings help doctors better understand and monitor for these potentially life-threatening complications.

Read More »

The Burden of Neonatal Invasive Candidiasis in Low- and Middle-income Countries: A Systematic Review and Meta-analysis

This study examined fungal blood infections in newborns across low- and middle-income countries, analyzing data from nearly 11,000 cases. Researchers found these infections occur more frequently and have higher death rates in poorer countries compared to wealthy nations. They identified that most infections are caused by Candida fungus species, and many of these fungi have become resistant to fluconazole, the most commonly used treatment drug.

Read More »

HIV protease inhibitors restore amphotericin B activity against Candida

Researchers discovered that HIV protease inhibitors, medications commonly used to treat HIV, can significantly enhance the effectiveness of amphotericin B, a powerful antifungal drug. When combined, these medications work synergistically to kill the dangerous fungus Candida auris, reduce its ability to form protective biofilms, and lower infection levels. This finding suggests a promising new treatment strategy for multidrug-resistant fungal infections that currently pose a serious global health threat.

Read More »

Modern Pro-Health Applications of Medicinal Mushrooms: Insights into the Polyporaceae Family, with a Focus on Cerrena unicolor

This review explores how medicinal mushrooms, particularly Cerrena unicolor, can be used to improve health through functional foods and supplements. The mushroom contains natural compounds with powerful properties including fighting cancer cells, killing harmful bacteria and viruses, and protecting the body from oxidative stress. Research shows these mushrooms could be incorporated into dairy products and other foods to create innovative health-promoting products for consumers.

Read More »

Cunninghamella echinulata DSM1905 biofilm-based L-asparaginase production in pneumatically-driven bioreactors

Scientists tested different types of bioreactors to grow a fungus called Cunninghamella echinulata that produces L-asparaginase, an enzyme used to treat leukemia and lymphoma. They found that a special hybrid bioreactor with a mesh scaffold allowed the fungus to form a biofilm, which produced significantly more of the therapeutic enzyme than other reactor types. This discovery could improve the production of cancer-fighting medications.

Read More »

Global status and trends of invasive pulmonary aspergillosis: A bibliometric study

This study analyzes 24 years of research on invasive pulmonary aspergillosis, a serious fungal infection in immunocompromised patients. Using bibliometric tools, researchers mapped out how the field has evolved, identifying leading countries (USA, Germany, China), key experts like David Denning and Thomas Walsh, and shifting research focus from transplant-related infections to COVID-19-associated cases. The analysis shows the field is rapidly growing with increasing emphasis on rapid diagnostic methods and antifungal therapies.

Read More »

ABPA in post-tuberculosis lung disease: A diagnostic pitfall or genuine entity?

After tuberculosis treatment, some patients develop fungal lung infections that can look very similar to an allergic fungal disease called ABPA. This editorial warns doctors that they need to be careful about diagnosing ABPA in tuberculosis patients because treating it with the wrong medications could make the fungal infection worse. The key difference is that true ABPA causes wheezing and asthma-like symptoms, while post-TB fungal infections cause cavities and scarring in the lungs.

Read More »
Scroll to Top